📰 Sight Sciences Inc News
Page 7 - Sight Sciences Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sight Sciences Inc. Real-time updates on events, politics, business and more.
August 4, 2023
Analysts’ price target changes for Friday, August 4th: Shift4 Payments (NYSE:FOUR) had its price target increased by Morgan Stanley from $50.00 to $52.00. They currently have an underweight rating on the stock. Q2 (NYSE:QTWO) had its target price raised by Morgan Stanley from $26.00 to $28.00. They currently have an equal weight rating on the […]
August 3, 2023
ConforMIS (CFMS) delivered earnings and revenue surprises of -34.85% and 2.71%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
August 2, 2023
Shares of Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month […]
July 30, 2023
Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 428,800 shares, a growth of 14.7% from the June 30th total of 373,700 shares. Based on an average trading volume of 120,700 shares, […]
July 21, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 90 points on Friday. Here are some big stocks recording gains in today’s session. Digital World Acquisition Corp. (NASDAQ: DWAC) climbed 69% to $22.59 after the company announced it reached a settlement with the SEC.
July 21, 2023
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 69% to $22.59 after the company announced it reached a settlement with the SEC.
July 20, 2023
MENLO PARK, Calif., July 20, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve...
July 20, 2023
Sight Sciences Inc (NASDAQ: SGHT) released the six-month SAHARA randomized controlled trial comparing interventional eyelid procedures enabled by TearCare Technology to Restasis 
July 20, 2023
MENLO PARK, Calif., July 20, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve...
July 19, 2023
Needham expects Glaukos Corp (NYSE: GKOS) to surpass expectations and raise outlook in Q2 FY23, fueled by rebounding iStent inject volumes post-2022 reimbursement-driven declines. An additional upside is expected from the accelerating iAccess and iPRIME launches.